Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In the Phase II trial, 73% to 94% of participants reported side effects with retatrutide, especially at the higher doses of 8 mg and 12 mg once weekly
Doses of approximately 3 g/day or more are associated with increased gastrointestinal side effects [1][11]
Injections can provide a quick and noticeable lift
BMC Med 14, 103 (2016).
Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical and regional aging research contexts, with limited exploratory human data
Cardiac Fail
US$ 28.72
US$ 23.66
US$ 21.76
US$ 24.93
US$ 23.17
US$ 20.94
US$ 28.31
US$ 23.85
US$ 23.54
